Results 51 to 60 of about 1,518,675 (340)

COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries

open access: yesNature Medicine, 2021
Widespread acceptance of COVID-19 vaccines is crucial for achieving sufficient immunization coverage to end the global pandemic, yet few studies have investigated COVID-19 vaccination attitudes in lower-income countries, where large-scale vaccination is ...
Julio S Solís Arce   +73 more
semanticscholar   +1 more source

COVID-19: Vaccines and therapeutics

open access: yesBioorganic & Medicinal Chemistry Letters, 2022
Coronavirus disease 2019 (COVID-19) is a communicable disease triggered by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged as leading cause of death from a single infectious agent globally. Despite of rigorous protective measures, availability of multiple vaccines and with few approved therapeutics, the virus effect on the ...
Ponnampalli, Swapna   +2 more
openaire   +2 more sources

Immunomodulation of COVID‐19 severity by helminth co‐infection: Implications for COVID‐19 vaccine efficacy

open access: yesImmunity, Inflammation and Disease, 2022
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), an emerging virus in late 2019 causing coronavirus disease 2019 (COVID‐19), has caused a catastrophic effect, resulting in an unprecedented global crisis.
Yibeltal Akelew   +4 more
doaj   +1 more source

COVID-19 Vaccine–Related Attitudes and Beliefs in Canada: National Cross-sectional Survey and Cluster Analysis

open access: yesJMIR Public Health and Surveillance, 2021
BackgroundThere are concerns that vaccine hesitancy may impede COVID-19 vaccine rollout and prevent the achievement of herd immunity. Vaccine hesitancy is a delay in acceptance or refusal of vaccines despite their availability.
Jamie L Benham   +16 more
doaj   +1 more source

Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape

open access: yesNature reviews. Immunology, 2021
Where 2020 saw the development and testing of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at an unprecedented pace, the first half of 2021 has seen vaccine rollout in many countries.
J. Tregoning   +4 more
semanticscholar   +1 more source

COVID-19 Vaccination and Glomerulonephritis [PDF]

open access: yesKidney International Reports, 2021
mRNA COVID-19 vaccine is more effective than traditional vaccines owing to superior immune activation. Nevertheless, the impact of mRNA COVID-19 vaccine on triggering de novo/relapsing glomerulonephritis (GN) is limited. We report a case series of patients who developed new or relapsing GN postvaccination.We evaluated baseline characteristics, vaccine ...
Nattawat Klomjit   +8 more
openaire   +2 more sources

ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine efficacy against the B.1.351 variant

open access: yesNew England Journal of Medicine, 2021
Background Assessing safety and efficacy of Covid-19 vaccines in different populations is essential, as is investigation of efficacy against emerging SARS-CoV-2 variants of concern including the B.1.351 (501Y.V2) variant first identified in South Africa.
S. Madhi   +50 more
semanticscholar   +1 more source

A qualitative study exploring the relationship between mothers’ vaccine hesitancy and health beliefs with COVID-19 vaccination intention and prevention during the early pandemic months

open access: yesHuman Vaccines & Immunotherapeutics, 2021
Vaccine hesitancy is a top ten global health threat that can negatively impact COVID-19 vaccine uptake. It is assumed that vaccine refusers hold deep, negative beliefs, while acceptors hold strong, positive beliefs.
Kimberly K. Walker   +3 more
doaj   +1 more source

COVID-19 Vaccines in Children

open access: yesJournal of Clinical Medicine, 2023
The COVID-19 pandemic has left an indelible mark on global health, affecting individuals of all ages across diverse communities. While the virus has predominantly been associated with severe outcomes in adults, its impact on children has garnered increasing attention. Today, three COVID-19 vaccines are available for use in the U.S.
Fayad, Danielle, Frenck, Robert W.
openaire   +2 more sources

Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.

open access: yesJournal of the American Medical Association (JAMA), 2022
Importance Assessing COVID-19 vaccine performance against the rapidly spreading SARS-CoV-2 Omicron variant is critical to inform public health guidance.
Emma K. Accorsi   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy